Cargando…

Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial

Immunization with Plasmodium falciparum (Pf) sporozoites under chemoprophylaxis (PfSPZ-CVac) is the most efficacious approach to malaria vaccination. Implementation is hampered by a complex chemoprophylaxis regimen and missing evidence for efficacy against heterologous infection. We report the resul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sulyok, Zita, Fendel, Rolf, Eder, Bianca, Lorenz, Freia-Raphaella, KC, Natasha, Karnahl, Matthias, Lalremruata, Albert, Nguyen, The T., Held, Jana, Adjadi, Folashade Almeine Cyntiche, Klockenbring, Torsten, Flügge, Judith, Woldearegai, Tamirat Gebru, Lamsfus Calle, Carlos, Ibáñez, Javier, Rodi, Miriam, Egger-Adam, Diane, Kreidenweiss, Andrea, Köhler, Carsten, Esen, Meral, Sulyok, Mihály, Manoj, Anita, Richie, Thomas L., Sim, B. Kim Lee, Hoffman, Stephen L., Mordmüller, Benjamin, Kremsner, Peter G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097064/ https://www.ncbi.nlm.nih.gov/pubmed/33947856 http://dx.doi.org/10.1038/s41467-021-22740-w

Ejemplares similares

A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection
por: Mordmüller, Benjamin, et al.
Publicado: (2022)

Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines
por: Richie, Thomas L., et al.
Publicado: (2015)

Progress with PfSPZ Vaccine, a radiation attenuated Plasmodium falciparum sporozoite vaccine
por: Billingsley, Peter, et al.
Publicado: (2014)

Safety and Immunogenicity of Radiation-Attenuated PfSPZ Vaccine in Equatoguinean Infants, Children, and Adults
por: Jongo, Said A., et al.
Publicado: (2023)

Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa
por: Silva, Joana C., et al.
Publicado: (2022)

Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean Adults
por: Jongo, Said A., et al.
Publicado: (2021)

Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens
por: Ibanez, Javier, et al.
Publicado: (2022)

Life-span of in vitro differentiated Plasmodium falciparum gametocytes
por: Gebru, Tamirat, et al.
Publicado: (2017)

Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacy
por: KC, Natasha, et al.
Publicado: (2022)

Multi-Dose Priming Regimens of PfSPZ Vaccine: Safety and Efficacy against Controlled Human Malaria Infection in Equatoguinean Adults
por: Jongo, Said Abdallah, et al.
Publicado: (2022)

PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial
por: Coulibaly, Drissa, et al.
Publicado: (2022)

Characterization of Plasmodium infections among inhabitants of rural areas in Gabon
por: Woldearegai, Tamirat Gebru, et al.
Publicado: (2019)

DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection
por: Sulyok, Mihály, et al.
Publicado: (2017)

Adaptive clinical trials of three PfSPZ products for development of a whole sporozoite vaccine that prevents Plasmodium falciparum infection, disease and transmission
por: Hoffman, Stephen L
Publicado: (2012)

Safety and Differential Antibody and T-Cell Responses to the Plasmodium falciparum Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants
por: Jongo, Said A., et al.
Publicado: (2019)

Caregiver and community perceptions and experiences participating in an infant malaria prevention trial of PfSPZ Vaccine administered by direct venous inoculation: a qualitative study in Siaya County, western Kenya
por: Achieng, Florence, et al.
Publicado: (2020)

1241. PfSPZ Vaccine Administered by Direct Venous Inoculation to Prevent Plasmodium falciparum Malaria is as Safe as Normal Saline – a Meta-analysis of 12 Randomized Controlled Clinical Trials
por: Church, L W Preston
Publicado: (2020)

Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria Infection
por: Lamsfus Calle, Carlos, et al.
Publicado: (2021)

Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon
por: Kreidenweiss, Andrea, et al.
Publicado: (2008)

Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men
por: Olotu, Ally, et al.
Publicado: (2018)

PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection
por: Murphy, Sean C., et al.
Publicado: (2021)

Non-Invasive Antibody Assessment in Saliva to Determine SARS-CoV-2 Exposure in Young Children
por: Heinzel, Constanze, et al.
Publicado: (2021)

Monitoring the threatened utility of malaria rapid diagnostic tests by novel high-throughput detection of Plasmodium falciparum hrp2 and hrp3 deletions: A cross-sectional, diagnostic accuracy study
por: Kreidenweiss, Andrea, et al.
Publicado: (2019)

Hemolysis Is Associated with Low Reticulocyte Production Index and Predicts Blood Transfusion in Severe Malarial Anemia
por: Fendel, Rolf, et al.
Publicado: (2010)

Spz/Toll-6 signal guides organotropic metastasis in Drosophila
por: Mishra-Gorur, Ketu, et al.
Publicado: (2019)

A call to caution when hydroxychloroquine is given to elderly patients with COVID-19
por: Gabor, Julian J., et al.
Publicado: (2021)

Assessment of malaria transmission intensity and insecticide resistance mechanisms in three rural areas of the Moyen Ogooué Province of Gabon
por: Boussougou-Sambe, Stravensky Térence, et al.
Publicado: (2022)

Boromycin has Rapid-Onset Antibiotic Activity Against Asexual and Sexual Blood Stages of Plasmodium falciparum
por: de Carvalho, Laís Pessanha, et al.
Publicado: (2022)

Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon
por: Gebru, Tamirat, et al.
Publicado: (2017)

Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trial
por: Nouatin, Odilon, et al.
Publicado: (2022)

The road to Cybathlon 2016 - Functional electrical stimulation cycling Team IRPT/SPZ
por: Laubacher, Marco, et al.
Publicado: (2017)

Immunosuppression in Malaria: Do Plasmodium falciparum Parasites Hijack the Host?
por: Calle, Carlos Lamsfus, et al.
Publicado: (2021)

Correction to: Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
por: Dejon-Agobé, Jean Claude, et al.
Publicado: (2021)

SARS-CoV-2 Antibodies Are Persisting in Saliva for More Than 15 Months After Infection and Become Strongly Boosted After Vaccination
por: Pinilla, Yudi T., et al.
Publicado: (2021)

2A and the Auxin-Based Degron System Facilitate Control of Protein Levels in Plasmodium falciparum
por: Kreidenweiss, Andrea, et al.
Publicado: (2013)

Molecular surveillance of mutations in the cytochrome b gene of Plasmodium falciparum in Gabon and Ethiopia
por: Gebru, Tamirat, et al.
Publicado: (2006)

Genome Sequence of Bacillus subtilis SPZ1, an Evolved Strain for Higher Uptake Rate of Tributyrin
por: Song, Ping, et al.
Publicado: (2013)

Neuron-Type Specific Functions of DNT1, DNT2 and Spz at the Drosophila Neuromuscular Junction
por: Sutcliffe, Ben, et al.
Publicado: (2013)

Complementary methods for SARS-CoV-2 diagnosis in times of material shortage
por: Sandri, Thaisa Lucas, et al.
Publicado: (2021)

Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients
por: Velavan, Thirumalaisamy P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_20sgg6hs435eimuoinnhqfa11m